ArticleGenome medicine2013

Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.

Ross L Prentice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.